Discussion on the chemotherapy of the reticuloses.
作者信息
WILKINSON J F, HADDOW A, NABARRO J D
出版信息
Proc R Soc Med. 1953 Sep;46(9):685-700. doi: 10.1177/003591575304600901.
Abstract
摘要
相似文献
1
Discussion on the chemotherapy of the reticuloses.
Proc R Soc Med. 1953 Sep;46(9):685-700. doi: 10.1177/003591575304600901.
2
Corticosteroids in the treatment of the reticuloses.
Br J Radiol. 1961 Sep;34:577-80. doi: 10.1259/0007-1285-34-405-577.
3
[Clinical features and internal therapy of reticuloses with special reference to lymphogranulomatosis].
Strahlentherapie. 1953;91(1):46-64.
4
[Radiotherapy of reticuloses with special reference to lymphogranulomatosis].
Strahlentherapie. 1953;91(1):65-80.
5
Evaluation of chemotherapeutic compounds in the reticuloses.
Br J Cancer. 1958 Sep;12(3):332-41. doi: 10.1038/bjc.1958.40.
6
TRIETHYLENE-MELAMINE.
Br Med J. 1955 Jun 4;1(4926):1380-1.
7
Treatment of Hodgkin's granuloma, chronic lymphatic leukaemia, polycythaemia vera, and other reticuloses with triethylenethiophosphoramide.
Lancet. 1956 Nov 17;271(6951):1017-21. doi: 10.1016/s0140-6736(56)90268-9.
8
CHANGES IN SERUM ALPHA-2 GLOBULINS IN RETICULOSES.
J Clin Pathol. 1964 Nov;17(6):651-4. doi: 10.1136/jcp.17.6.651.
9
Nitrogen mustards in Hodgkin's disease; report on 21 cases and four of other reticuloses.
Lancet. 1947 Jun 28;1(6461):899-901.
10
Chemotherapy in the reticuloses.
Med J Aust. 1952 Jan 12;1(2):38-43.
引用本文的文献
1
Further studies on incomplete carcinogenesis: triethylene melamine (T.E.M.), 1,2-benzanthracene and beta-propiolactone, as initiators of skin tumour formation in the mouse.
Br J Cancer. 1955 Mar;9(1):177-203. doi: 10.1038/bjc.1955.14.
2
[Long-term chemotherapy of chronic myeloid leukemia with Myleran and C69].
Klin Wochenschr. 1962 Jun 15;40:622-31. doi: 10.1007/BF01479067.
3
Mannomustine in treatment of leukaemias, polycythaemia, and malignant disorders.
Br Med J. 1959 Aug 22;2(5146):208-13. doi: 10.1136/bmj.2.5146.208.
4
Breast cancer; a new approach to therapy.
Br Med J. 1959 May 23;1(5133):1315-20. doi: 10.1136/bmj.1.5133.1315.
5
Medullary aplasia in chronic myeloid leukaemia during busulphan therapy.
Br Med J. 1957 Dec 21;2(5059):1468-71. doi: 10.1136/bmj.2.5059.1468.
6
[Present status of chemotherapy in human neoplastic diseases].
Klin Wochenschr. 1957 May 1;35(9):440-8. doi: 10.1007/BF01477945.
7
Immediate and remote results of chloroethylamine treatment of Hodgkin's disease.
Br Med J. 1956 Feb 4;1(4961):252-6. doi: 10.1136/bmj.1.4961.252.
8
The present status of radiotherapy and chemotherapy in the treatment of chronic leukaemia; a review.
Postgrad Med J. 1954 Feb;30(340):93-9. doi: 10.1136/pgmj.30.340.93.
本文引用的文献
1
Folic acid.
Br Med J. 1948 Apr 24;1(4555):771; passim. doi: 10.1136/bmj.1.4555.771.
2
Nitrogen mustard therapy with special reference to Hodgkin's disease.
Br Med J. 1949 Sep 17;2(4628):622-5. doi: 10.1136/bmj.2.4628.622.
3
New cytotoxic agents with tumour-inhibitory activity.
Nature. 1950 Jun 24;165(4208):993-6. doi: 10.1038/165993a0.
4
Triaethyleneimino-s-triazine in human malignant disease: a preliminary trial.
Br J Cancer. 1951 Mar;5(1):28-37. doi: 10.1038/bjc.1951.3.
5
Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.
AMA Arch Intern Med. 1951 Apr;87(4):477-516. doi: 10.1001/archinte.1951.03810040002001.
6
Treatment of acute leukemia with aminopterin.
Lancet. 1951 Feb 10;1(6650):325-7. doi: 10.1016/s0140-6736(51)92298-2.
7
Trial of beta-naphthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders.
Lancet. 1951 Jan 20;1(6647):137-9. doi: 10.1016/s0140-6736(51)91214-7.
8
Myleran in chronic myeloid leukaemia; results of treatment.
Lancet. 1953 Jan 31;264(6753):208-13. doi: 10.1016/s0140-6736(53)90885-x.
Zotero 插件